comparemela.com
Home
Live Updates
FDA Grants Tina-qant Lp(a) Assay Breakthrough Device Designation : comparemela.com
FDA Grants Tina-qant Lp(a) Assay Breakthrough Device Designation
A lipoprotein (a) (Lp[a]) assay has been granted breakthrough device designation to expand identification of patients with elevated Lp(a) and genetic predispositions to cardiovascular disease.
Related Keywords
United States ,
Canada ,
Canadian ,
American ,
,
National Heart ,
European Atherosclerosis Society ,
Blood Institute ,
American Heart Association ,
Canadian Cardiovascular Society ,
Device Designation ,
Show Lepodisiran Was Well Tolerated ,
Substantially Lowered Lipoprotein ,
American Heart ,
Accessed May ,
Adv Exp Med ,
comparemela.com © 2020. All Rights Reserved.